These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 25152656)

  • 1. Patient-reported outcomes before and after treatment of major depressive disorder.
    IsHak WW; Mirocha J; Pi S; Tobia G; Becker B; Peselow ED; Cohen RM
    Dialogues Clin Neurosci; 2014 Jun; 16(2):171-83. PubMed ID: 25152656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient-reported outcomes of quality of life, functioning, and depressive symptom severity in major depressive disorder comorbid with panic disorder before and after SSRI treatment in the star*d trial.
    IsHak WW; Mirocha J; Christensen S; Wu F; Kwock R; Behjat J; Pi S; Akopyan A; Peselow ED; Cohen RM; Elashoff D
    Depress Anxiety; 2014 Aug; 31(8):707-16. PubMed ID: 23861180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality of Life, Functioning, and Depressive Symptom Severity in Older Adults With Major Depressive Disorder Treated With Citalopram in the STAR*D Study.
    Steiner AJ; Recacho J; Vanle B; Dang J; Wright SM; Miller JS; Kauzor K; Reid M; Bashmi LE; Mirocha J; Danovitch I; IsHak WW
    J Clin Psychiatry; 2017 Jul; 78(7):897-903. PubMed ID: 28858443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incorporating multidimensional patient-reported outcomes of symptom severity, functioning, and quality of life in the Individual Burden of Illness Index for Depression to measure treatment impact and recovery in MDD.
    Cohen RM; Greenberg JM; IsHak WW
    JAMA Psychiatry; 2013 Mar; 70(3):343-50. PubMed ID: 23303512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of Patient-reported Outcomes of Quality of Life and Functioning Before and After Treatment of Major Depressive Disorder Comorbid With Alcohol Use Disorders.
    Danovitch I; Steiner AJ; Kazdan A; Goldenberg M; Haglund M; Mirocha J; Collison K; Vanle B; Dang J; IsHak WW
    J Addict Med; 2017; 11(1):47-54. PubMed ID: 27763941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Major Depressive Disorder in Patients With Doctoral Degrees: Patient-reported Depressive Symptom Severity, Functioning, and Quality of Life Before and After Initial Treatment in the STAR*D Study.
    Steiner AJ; Boulos N; Wright SM; Mirocha J; Smith K; López E; Gohar SH; Ishak WW
    J Psychiatr Pract; 2017 Sep; 23(5):328-341. PubMed ID: 28961662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting relapse in major depressive disorder using patient-reported outcomes of depressive symptom severity, functioning, and quality of life in the Individual Burden of Illness Index for Depression (IBI-D).
    Ishak WW; Greenberg JM; Cohen RM
    J Affect Disord; 2013 Oct; 151(1):59-65. PubMed ID: 23790554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Major Depression Comorbid with Medical Conditions: Analysis of Quality of Life, Functioning, and Depressive Symptom Severity.
    IsHak WW; Steiner AJ; Klimowicz A; Kauzor K; Dang J; Vanle B; Elzahaby C; Reid M; Sumner L; Danovitch I
    Psychopharmacol Bull; 2018 Jan; 48(1):8-25. PubMed ID: 29382957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality of Life and Functioning in Comorbid Posttraumatic Stress Disorder and Major Depressive Disorder After Treatment With Citalopram Monotherapy.
    Steiner AJ; Boulos N; Mirocha J; Wright SM; Collison KL; IsHak WW
    Clin Neuropharmacol; 2017; 40(1):16-23. PubMed ID: 27764051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sexual satisfaction and quality of life in major depressive disorder before and after treatment with citalopram in the STAR*D study.
    Ishak WW; Christensen S; Sayer G; Ha K; Li N; Miller J; Nguyen JM; Cohen RM
    J Clin Psychiatry; 2013 Mar; 74(3):256-61. PubMed ID: 23561231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A descriptive analysis of quality of life using patient-reported measures in major depressive disorder in a naturalistic outpatient setting.
    Ishak WW; Balayan K; Bresee C; Greenberg JM; Fakhry H; Christensen S; Rapaport MH
    Qual Life Res; 2013 Apr; 22(3):585-96. PubMed ID: 22544416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality of life in major depressive disorder before/after multiple steps of treatment and one-year follow-up.
    IsHak WW; Mirocha J; James D; Tobia G; Vilhauer J; Fakhry H; Pi S; Hanson E; Nashawati R; Peselow ED; Cohen RM
    Acta Psychiatr Scand; 2015 Jan; 131(1):51-60. PubMed ID: 24954156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality of life and functioning of Hispanic patients with Major Depressive Disorder before and after treatment.
    López E; Steiner AJ; Manier K; Shapiro BB; Vanle B; Parisi T; Dang J; Chang T; Ganjian S; Mirocha J; Danovitch I; IsHak WW
    J Affect Disord; 2018 Jan; 225():117-122. PubMed ID: 28826087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Humanistic outcomes in treatment resistant depression: a secondary analysis of the STAR*D study.
    DiBernardo A; Lin X; Zhang Q; Xiang J; Lu L; Jamieson C; Benson C; Lee K; Bodén R; Brandt L; Brenner P; Reutfors J; Li G
    BMC Psychiatry; 2018 Oct; 18(1):352. PubMed ID: 30373547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of fatigue on outcome of selective serotonin reuptake inhibitor treatment: secondary analysis of STAR*D.
    Ferguson M; Dennehy EB; Marangell LB; Martinez J; Wisniewski SR
    Curr Med Res Opin; 2014 Oct; 30(10):2109-18. PubMed ID: 24949937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does comorbid substance use disorder impair recovery from major depression with SSRI treatment? An analysis of the STAR*D level one treatment outcomes.
    Davis LL; Wisniewski SR; Howland RH; Trivedi MH; Husain MM; Fava M; McGrath PJ; Balasubramani GK; Warden D; Rush AJ
    Drug Alcohol Depend; 2010 Mar; 107(2-3):161-70. PubMed ID: 19945804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Children of depressed mothers 1 year after the initiation of maternal treatment: findings from the STAR*D-Child Study.
    Pilowsky DJ; Wickramaratne P; Talati A; Tang M; Hughes CW; Garber J; Malloy E; King C; Cerda G; Sood AB; Alpert JE; Trivedi MH; Fava M; Rush AJ; Wisniewski S; Weissman MM
    Am J Psychiatry; 2008 Sep; 165(9):1136-47. PubMed ID: 18558646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relief of depression and pain improves daily functioning and quality of life in patients with major depressive disorder.
    Lin CH; Yen YC; Chen MC; Chen CC
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Dec; 47():93-8. PubMed ID: 23989033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcranial magnetic stimulation (TMS) for major depression: a multisite, naturalistic, observational study of quality of life outcome measures in clinical practice.
    Janicak PG; Dunner DL; Aaronson ST; Carpenter LL; Boyadjis TA; Brock DG; Cook IA; Lanocha K; Solvason HB; Bonneh-Barkay D; Demitrack MA
    CNS Spectr; 2013 Dec; 18(6):322-32. PubMed ID: 23895940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors associated with health-related quality of life among outpatients with major depressive disorder: a STAR*D report.
    Trivedi MH; Rush AJ; Wisniewski SR; Warden D; McKinney W; Downing M; Berman SR; Farabaugh A; Luther JF; Nierenberg AA; Callan JA; Sackeim HA
    J Clin Psychiatry; 2006 Feb; 67(2):185-95. PubMed ID: 16566612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.